annual book value:
$778.35M-$91.78M(-10.55%)Summary
- As of today (July 1, 2025), PCRX annual book value is $778.35 million, with the most recent change of -$91.78 million (-10.55%) on December 31, 2024.
- During the last 3 years, PCRX annual book value has risen by +$47.94 million (+6.56%).
- PCRX annual book value is now -10.55% below its all-time high of $870.13 million, reached on December 31, 2023.
Performance
PCRX Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$798.54M+$20.19M(+2.59%)Summary
- As of today (July 1, 2025), PCRX quarterly book value is $798.54 million, with the most recent change of +$20.19 million (+2.59%) on March 31, 2025.
- Over the past year, PCRX quarterly book value has dropped by -$93.62 million (-10.49%).
- PCRX quarterly book value is now -10.49% below its all-time high of $892.16 million, reached on March 31, 2024.
Performance
PCRX quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
PCRX Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.6% | -10.5% |
| 3 y3 years | +6.6% | +12.5% |
| 5 y5 years | +119.3% | +113.5% |
PCRX Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +6.6% | -10.5% | +6.5% |
| 5 y | 5-year | -10.6% | +119.3% | -10.5% | +105.7% |
| alltime | all time | -10.6% | +1708.5% | -10.5% | +1750.3% |
PCRX Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $798.54M(+2.6%) |
| Dec 2024 | $778.35M(-10.5%) | $778.35M(+3.8%) |
| Sep 2024 | - | $749.58M(-14.8%) |
| Jun 2024 | - | $879.28M(-1.4%) |
| Mar 2024 | - | $892.16M(+2.5%) |
| Dec 2023 | $870.13M(+12.3%) | $870.13M(+4.6%) |
| Sep 2023 | - | $831.55M(+2.9%) |
| Jun 2023 | - | $807.98M(+5.2%) |
| Mar 2023 | - | $768.04M(-0.9%) |
| Dec 2022 | $775.01M(+6.1%) | $775.01M(+0.6%) |
| Sep 2022 | - | $770.12M(+1.8%) |
| Jun 2022 | - | $756.64M(+6.6%) |
| Mar 2022 | - | $709.58M(-2.9%) |
| Dec 2021 | $730.41M(+17.9%) | $730.41M(+1.6%) |
| Sep 2021 | - | $718.60M(+4.6%) |
| Jun 2021 | - | $687.17M(+5.6%) |
| Mar 2021 | - | $650.82M(+5.0%) |
| Dec 2020 | $619.69M(+74.6%) | $619.69M(+6.0%) |
| Sep 2020 | - | $584.69M(+50.6%) |
| Jun 2020 | - | $388.15M(+3.8%) |
| Mar 2020 | - | $374.04M(+5.4%) |
| Dec 2019 | $354.94M(+10.5%) | $354.94M(+2.5%) |
| Sep 2019 | - | $346.16M(+1.3%) |
| Jun 2019 | - | $341.65M(+4.3%) |
| Mar 2019 | - | $327.52M(+2.0%) |
| Dec 2018 | $321.23M(+14.9%) | $321.23M(+6.6%) |
| Sep 2018 | - | $301.27M(+3.7%) |
| Jun 2018 | - | $290.51M(+4.3%) |
| Mar 2018 | - | $278.52M(-0.3%) |
| Dec 2017 | $279.48M | $279.48M(+5.5%) |
| Sep 2017 | - | $264.80M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $261.05M(-3.5%) |
| Mar 2017 | - | $270.63M(+23.6%) |
| Dec 2016 | $218.98M(+0.3%) | $218.98M(+2.3%) |
| Sep 2016 | - | $214.15M(-6.2%) |
| Jun 2016 | - | $228.35M(+1.0%) |
| Mar 2016 | - | $226.17M(+3.6%) |
| Dec 2015 | $218.39M(+27.6%) | $218.39M(+4.5%) |
| Sep 2015 | - | $209.01M(+7.0%) |
| Jun 2015 | - | $195.28M(+6.1%) |
| Mar 2015 | - | $184.02M(+7.5%) |
| Dec 2014 | $171.15M(+314.9%) | $171.15M(+10.4%) |
| Sep 2014 | - | $155.07M(+4.8%) |
| Jun 2014 | - | $147.97M(+314.4%) |
| Mar 2014 | - | $35.71M(-13.4%) |
| Dec 2013 | $41.25M(-37.4%) | $41.25M(-16.0%) |
| Sep 2013 | - | $49.12M(-16.9%) |
| Jun 2013 | - | $59.14M(-15.3%) |
| Mar 2013 | - | $69.79M(+6.0%) |
| Dec 2012 | $65.86M(+36.4%) | $65.86M(-18.1%) |
| Sep 2012 | - | $80.44M(-14.9%) |
| Jun 2012 | - | $94.50M(+153.8%) |
| Mar 2012 | - | $37.24M(-22.8%) |
| Dec 2011 | $48.27M(-199.8%) | $48.27M(+247.9%) |
| Sep 2011 | - | $13.88M(-39.5%) |
| Jun 2011 | - | $22.93M(-26.4%) |
| Mar 2011 | - | $31.15M(-164.4%) |
| Dec 2010 | -$48.39M(+110.8%) | -$48.39M(+12.4%) |
| Sep 2010 | - | -$43.04M(+25.5%) |
| Jun 2010 | - | -$34.30M(+49.4%) |
| Dec 2009 | -$22.95M(-406.7%) | -$22.95M |
| Dec 2008 | $7.48M | - |
FAQ
- What is Pacira BioSciences annual book value?
- What is the all time high annual book value for Pacira BioSciences?
- What is Pacira BioSciences annual book value year-on-year change?
- What is Pacira BioSciences quarterly book value?
- What is the all time high quarterly book value for Pacira BioSciences?
- What is Pacira BioSciences quarterly book value year-on-year change?
What is Pacira BioSciences annual book value?
The current annual book value of PCRX is $778.35M
What is the all time high annual book value for Pacira BioSciences?
Pacira BioSciences all-time high annual book value is $870.13M
What is Pacira BioSciences annual book value year-on-year change?
Over the past year, PCRX annual book value has changed by -$91.78M (-10.55%)
What is Pacira BioSciences quarterly book value?
The current quarterly book value of PCRX is $798.54M
What is the all time high quarterly book value for Pacira BioSciences?
Pacira BioSciences all-time high quarterly book value is $892.16M
What is Pacira BioSciences quarterly book value year-on-year change?
Over the past year, PCRX quarterly book value has changed by -$93.62M (-10.49%)